# EDGAR Filing Document

**Accession Number:** 0001529864
**File Stem:** 0000950170-25-098354
**Filing Date:** 2025-7
**Character Count:** 30231
**Document Hash:** 2f575029a058c29f3e02660e50be81c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-098354.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0000950170-25-098354

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20250724

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Enova International, Inc.
- **CENTRAL INDEX KEY:** 0001529864
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERSONAL CREDIT INSTITUTIONS [6141]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 453190813
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35503
- **FILM NUMBER:** 251147127

**BUSINESS ADDRESS:**
- **STREET 1:** 175 WEST JACKSON BLVD.
- **STREET 2:** SUITE 600
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60604
- **BUSINESS PHONE:** 312-568-4200

**MAIL ADDRESS:**
- **STREET 1:** 175 WEST JACKSON BLVD.
- **STREET 2:** SUITE 600
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60604

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## **FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** July 24, 2025<br>

------

ENOVA INTERNATIONAL, INC.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 1-35503 | 45-3190813 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 175 West Jackson Boulevard |  |  |
| Chicago**,** Illinois |  | 60604 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 312 568-4200<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, $.00001 par value per share | ENVA | New York Stock Exchange LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## **Item 2.02 Results of Operations and Financial Condition.** 
On July 24, 2025, Enova International, Inc. (the "Company") issued a press release to announce its consolidated financial results for the three months ended June 30, 2025. A copy of the Company's press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information included or incorporated by reference in this Current Report on Form 8-K under this Item 2.02 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

## **Item 9.01 Financial Statements and Exhibits.** 
(d) Exhibits

The following exhibits are furnished as part of this Report on Form 8-K:

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| [<u>99.1</u>](enva-ex99_1.htm) | [<u>Enova International, Inc. press release dated July 24, 2025</u>](enva-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | Enova International, Inc. |
| Date: | July 24, 2025 | By:  | /s/ Sean Rahilly |
|  |  |  | Sean Rahilly<br>General Counsel & Secretary |

---

------

## Exhibit 99.1

**Exhibit 99.1**

**Enova Reports Second Quarter 2025 Results** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Originations rose 28% and total company revenue increased 22% from the second quarter of 2024

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Diluted earnings per share of $2.86 increased 48% and adjusted earnings per share<sup>1</sup> of $3.23 rose 46% compared to the second quarter of 2024

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Consolidated credit performance remained strong with a net charge-off ratio of 8.1% and net revenue margin of 58%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Year-over-year improvement in the consolidated 30+ day delinquency ratio of 7.1% and stability in the consolidated portfolio fair value premium of 115% reflect a stable credit outlook

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Liquidity, including cash and marketable securities and available capacity on facilities, totaled $1.1 billion at June 30th

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Share repurchases during the quarter totaled $54 million

"We are pleased to report another quarter of strong performance," said David Fisher, Enova's CEO. "For the fifth quarter in a row, we generated greater than 20% year-over-year growth in revenue, originations and adjusted EPS. We remain committed to prudently managing the business to produce sustainable and profitable growth, and we believe our diversified business, strong competitive position, world-class team, advanced technology and analytics platform position us very well for the remainder of this year and beyond."

**Second Quarter 2025 Summary**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Total revenue of $764 million increased 22% from $628 million in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Net revenue margin of 58% compared to 59% in the second quarter of 2024, reflecting continued solid credit performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Net income of $76 million, or $2.86 per diluted share, increased 41% from $54 million, or $1.93 per diluted share, in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA<sup>1</sup> of $203 million increased 25% from $163 million in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted earnings per share<sup>1</sup> of $3.23 increased 46% from $2.21 per diluted share in the second quarter of 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Total company combined loans and finance receivables<sup>1</sup> increased 20% from the end of the second quarter of 2024 to a record $4.3 billion with total company originations of $1.8 billion in the quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Repurchased $54 million of common stock under the company's share repurchase program.

"Our second quarter results reflect the strength of our diversified product offerings and the ability of our team to deliver strong originations growth, revenue and profitability while maintaining solid credit," said Steve Cunningham, CFO of Enova. "Our focused growth strategy, sophisticated unit economics decisioning and solid

------

<sup>1</sup> Non-GAAP measure. Refer to "Non-GAAP Financial Measures," "Loans and Finance Receivables Financial and Operating Data,"<br> and "Reconciliation of GAAP to Non-GAAP Financial Measures" below for additional information.

------

balance sheet support our ability to successfully navigate a range of operating environments and deliver on our commitment to driving long-term shareholder value through both continued investments in our business and share repurchases."

**Enova Announces Planned Key Senior Leadership Changes**

Enova today announced planned key senior leadership changes, which reflect the Company's long-term leadership transition planning. David Fisher, Enova's Chairman of the Board and Chief Executive Officer, will transition to the role of Executive Chairman of the Board of Directors, effective January 1, 2026, and will continue to lead the Board of Directors on company strategy while supporting stability and continuity during the leadership transitions. Fisher intends to serve as Executive Chairman for at least two years. Steve Cunningham, Enova's current Chief Financial Officer, will succeed Fisher as CEO, effective January 1, 2026. In addition, Cunningham has joined the Board of Directors, effective immediately. Scott Cornelis, current Treasurer and Vice President of Finance for Enova, will succeed Steve Cunningham as CFO, effective January 1, 2026. The details of the announcement can be accessed here.

**Conference Call**

Enova will host a conference call to discuss its second quarter 2025 results at 4 p.m. Central Time / 5 p.m. Eastern Time today, July 24<sup>th</sup>. The live webcast of the call can be accessed at the Enova Investor Relations website at http://ir.enova.com, along with the company's earnings press release and supplemental financial information. The U.S. dial-in for the call is 1-855-560-2575 (1-412-542-4161 for non-U.S. callers). Please ask to join the Enova International call. A replay of the conference call will be available until July 31, 2025, at 10:59 p.m. Central Time / 11:59 p.m. Eastern Time, while an archived version of the webcast will be available on the Enova International Investor Relations website for 90 days. The U.S. dial-in for the conference call replay is 1-877-344-7529 (1-412-317-0088). The replay access code is 9191893.

**About Enova**

**SOURCE Enova International, Inc.**

For further information:

Public Relations Contact:

Erin Yeager

Email: media@enova.com

Investor Relations Contact:

Lindsay Savarese

Office: 1-212-331-8417

Email: IR@enova.com

------

**Cautionary Statement Concerning Forward Looking Statements**

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about the business, financial condition and prospects of Enova. These forward-looking statements give current expectations or forecasts of future events and reflect the views and assumptions of Enova's senior management with respect to the business, financial condition and prospects of Enova as of the date of this release and are not guarantees of future performance. The actual results of Enova could differ materially from those indicated by such forward-looking statements because of various risks and uncertainties applicable to Enova's business, including, without limitation, those risks and uncertainties indicated in Enova's filings with the Securities and Exchange Commission ("SEC"), including our annual report on Form 10-K, quarterly reports on Forms 10-Q and current reports on Forms 8-K. These risks and uncertainties are beyond the ability of Enova to control, and, in many cases, Enova cannot predict all of the risks and uncertainties that could cause its actual results to differ materially from those indicated by the forward-looking statements. When used in this release, the words "believes," "estimates," "plans," "expects," "anticipates" and similar expressions or variations as they relate to Enova or its management are intended to identify forward-looking statements. Enova cautions you not to put undue reliance on these statements. Enova disclaims any intention or obligation to update or revise any forward-looking statements after the date of this release.

**Non-GAAP Financial Measures**

In addition to the financial information prepared in conformity with generally accepted accounting principles in the United States, or GAAP, Enova provides historical non-GAAP financial information. Enova presents non-GAAP financial information because such measures are used by management in understanding the activities and business metrics of Enova's operations. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of Enova's business that, when viewed with its GAAP results, provide a more complete understanding of factors and trends affecting its business.

Management provides non-GAAP financial information for informational purposes and to enhance understanding of Enova's GAAP consolidated financial statements. Readers should consider the information in addition to, but not instead of or superior to, Enova's financial statements prepared in accordance with GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes.

*Combined Loans and Finance Receivables*

The combined loans and finance receivables measures are non-GAAP measures that include loans and finance receivables that Enova owns or has purchased and loans that Enova guarantees. Management believes these non-GAAP measures provide management and investors with important information needed to evaluate the magnitude of potential receivable losses and the opportunity for revenue performance of the loans and finance receivable portfolio on an aggregate basis. Management also believes that the comparison of the aggregate amounts from period to period is more meaningful than comparing only the amounts reflected on Enova's consolidated balance sheet since revenue is impacted by the aggregate amount of receivables owned by Enova and those guaranteed by Enova as reflected in its consolidated financial statements.

------

*Adjusted Earnings Measures*

Enova provides adjusted earnings and adjusted earnings per share, or, collectively, the Adjusted Earnings Measures, which are non-GAAP measures. Management believes that the presentation of these measures provides investors with greater transparency and facilitates comparison of operating results across a broad spectrum of companies with varying capital structures, compensation strategies, derivative instruments and amortization methods, which can provide a more complete understanding of Enova's financial performance, competitive position and prospects for the future. Management utilizes, and also believes that investors utilize, the Adjusted Earnings Measures to assess operating performance, recognizing that such measures may highlight trends in Enova's business that may not otherwise be apparent when relying on financial measures calculated in accordance with GAAP. In addition, management believes that the Adjusted Earnings Measures are useful to management and investors in comparing Enova's financial results during the periods shown without the effect of certain items that are not indicative of Enova's core operating performance or results of operations.

*Adjusted EBITDA Measures*

Enova provides Adjusted EBITDA and Adjusted EBITDA margin, or, collectively, the Adjusted EBITDA measures, which are non-GAAP measures. Adjusted EBITDA is a non-GAAP measure that Enova defines as earnings excluding depreciation, amortization, interest, foreign currency transaction gains or losses, taxes, stock-based compensation and certain other items, as appropriate, that are not indicative of our core operating performance. Adjusted EBITDA margin is a non-GAAP measure that Enova defines as Adjusted EBITDA as a percentage of total revenue. Management utilizes, and also believes that investors utilize, Adjusted EBITDA Measures to analyze operating performance and evaluate Enova's ability to incur and service debt and Enova's capacity for making capital expenditures. Enova believes that Adjusted EBITDA is useful to management and investors in comparing Enova's financial results during the periods shown without the effect of certain non-cash items and certain items that are not indicative of Enova's core operating performance or results of operations. Adjusted EBITDA Measures are also useful to investors to help assess Enova's estimated enterprise value.

------

**ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES** 

**CONSOLIDATED BALANCE SHEETS** 

*(dollars in thousands, except per share data)* 

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
|  | **June 30,** | **June 30,** | **December 31,** |
|  | **2025** | **2024** | **2024** |
| **Assets** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $55560 | $60138 | $73910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 323883 | 211167 | 248758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans and finance receivables at fair value | 4773315 | 3939159 | 4386444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable | 35586 | 68732 | 40690 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other receivables and prepaid expenses | 78045 | 71172 | 63752 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 127686 | 115061 | 119956 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 17781 | 13180 | 18201 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 279275 | 279275 | 279275 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 6923 | 14978 | 10951 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 26699 | 44229 | 24194 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $5724753 | $4817091 | $5266131 |
| **Liabilities and Stockholders' Equity** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $257509 | $333972 | $249970 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 32654 | 26511 | 32165 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax liabilities, net | 242421 | 114959 | 223590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | 3963514 | 3194121 | 3563482 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 4496098 | 3669563 | 4069207 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitments and contingencies |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Stockholders' equity: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.00001 par value, 250,000,000 shares authorized, 47,176,544, 46,373,689 and 46,520,916 shares issued and 25,070,028, 26,498,011 and 25,808,096 outstanding as of June 30, 2025 and 2024 and December 31, 2024, respectively |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.00001 par value, 25,000,000 shares authorized, no shares issued and outstanding |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid in capital | 346926 | 308481 | 328268 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1846848 | 1590645 | 1697754 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (8853) | (10749) | (13691) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost (22,106,516, 19,875,678 and 20,712,820 shares as of June 30, 2025 and 2024 and December 31, 2024, respectively) | (956266) | (740849) | (815407) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1228655 | 1147528 | 1196924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $5724753 | $4817091 | $5266131 |

---

------

**ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENTS OF INCOME** 

*(in thousands, except per share data)* 

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Revenue** | $764043 | $628436 | $1509584 | $1238325 |
| **Change in Fair Value** | (322585) | (258245) | (641944) | (522268) |
| **Net Revenue** | 441458 | 370191 | 867640 | 716057 |
| **Operating Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Marketing | 142848 | 120765 | 282139 | 231332 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operations and technology | 63648 | 54953 | 126110 | 109332 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 40508 | 39708 | 82972 | 79573 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 10348 | 9709 | 20409 | 19972 |
| **Total Operating Expenses** | 257352 | 225135 | 511630 | 440209 |
| **Income from Operations** | 184106 | 145056 | 356010 | 275848 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (82781) | (70954) | (163325) | (136551) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency transaction gain (loss) | 134 | (19) | (318) | (67) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment income | 613 |  | 733 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other nonoperating expenses | (1019) | (521) | (1019) | (1013) |
| **Income before Income Taxes** | 101053 | 73562 | 192081 | 138217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 24904 | 19651 | 42987 | 35878 |
| **Net income** | $76149 | $53911 | $149094 | $102339 |
| **Earnings Per Share** |  |  |  |  |
| Earnings per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $3.01 | $2.00 | $5.85 | $3.71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $2.86 | $1.93 | $5.51 | $3.56 |
| Weighted average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 25297 | 26938 | 25486 | 27567 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 26646 | 27941 | 27062 | 28722 |

---

------

**ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES** 

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW** 

*(dollars in thousands)* 

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
|  | **2025** | **2024** |
| **Total cash flows provided by operating activities** | $838508 | $709505 |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loans and finance receivables | (1013727) | (827638) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalization of software development costs and purchases of fixed assets | (24099) | (22312) |
| **Total cash flows used in investing activities** | (1037826) | (849950) |
| **Cash flows provided by financing activities** | 255953 | 35159 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 140 | (848) |
| **Net increase (decrease) in cash, cash equivalents and restricted cash** | 56775 | (106134) |
| **Cash, cash equivalents and restricted cash at beginning of year** | 322668 | 377439 |
| **Cash, cash equivalents and restricted cash at end of period** | $379443 | $271305 |

---

------

**ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES** 

**LOANS AND FINANCE RECEIVABLES FINANCIAL AND OPERATING DATA** 

*(dollars in thousands)* 

The following table includes financial information for loans and finance receivables, which is based on loan and finance receivable balances for the three months ended June 30, 2025 and 2024.

---

| | | | |
|:---|:---|:---|:---|
| **<u>Three Months Ended June 30,</u>** | **2025** | **2024** | **Change** |
| **Ending combined loan and finance receivable principal balance:** |  |  |  |
| Company owned | $4141113 | $3423652 | $717461 |
| Guaranteed by the Company<sup>(a)</sup> | 16762 | 12487 | 4275 |
| **Total combined loan and finance receivable principal balance**<sup>(b)</sup> | $4157875 | $3436139 | $721736 |
| **Ending combined loan and finance receivable fair value balance:** |  |  |  |
| Company owned | $4773315 | $3939159 | $834156 |
| Guaranteed by the Company<sup>(a)</sup> | 23777 | 17284 | 6493 |
| **Ending combined loan and finance receivable fair value balance**<sup>(b)</sup> | $4797092 | $3956443 | $840649 |
| Fair value as a % of principal<sup>(c)</sup> | 115.4% | 115.1% | 0.3% |
| **Ending combined loan and finance receivable balance, including principal and accrued fees/interest outstanding:** |  |  |  |
| Company owned | $4298675 | $3569726 | $728949 |
| Guaranteed by the Company<sup>(a)</sup> | 20014 | 14941 | 5073 |
| **Ending combined loan and finance receivable balance**<sup>(b)</sup> | $4318689 | $3584667 | $734022 |
| **Average combined loan and finance receivable balance, including principal and accrued fees/interest outstanding:** |  |  |  |
| Company owned<sup>(d)</sup> | $4201674 | $3485739 | $715935 |
| Guaranteed by the Company<sup>(a)(d)</sup> | 18495 | 13730 | 4765 |
| **Average combined loan and finance receivable balance**<sup>(a)(d)</sup> | $4220169 | $3499469 | $720700 |
| Installment loans as percentage of average combined loan and finance receivable balance | 44.2% | 47.7% | (3.5)% |
| Line of credit accounts as percentage of average combined loan and finance receivable balance | 55.8% | 52.3% | 3.5% |
| Revenue | $754577 | $619340 | $135237 |
| Change in fair value | (320556) | (255980) | (64576) |
| Net revenue | $434021 | $363360 | $70661 |
| Net revenue margin | 57.5% | 58.7% | (1.2)% |
| Combined loan and finance receivable originations and purchases | $1803049 | $1408654 | $394395 |
| **<u>Delinquencies:</u>** |  |  |  |
| >30 days delinquent | $305583 | $268053 | $37530 |
| >30 days delinquent as a % of combined loan and finance receivable balance<sup>(c)</sup> | 7.1% | 7.5% | (0.4)% |
| **<u>Charge-offs:</u>** |  |  |  |
| Charge-offs (net of recoveries) | $342880 | $268386 | $74494 |
| Charge-offs (net of recoveries) as a % of average combined loan and finance receivable balance<sup>(d)</sup> | 8.1% | 7.7% | 0.4% |

---

------

*(a) Represents loans originated by third-party lenders through the CSO programs, which are not included in our consolidated balance sheets.* 

*(b) Non-GAAP measure.*

*(c) Determined using period-end balances.*

*(d) The average combined loan and finance receivable balance is the average of the month-end balances during the period.*

------

**ENOVA INTERNATIONAL, INC. AND SUBSIDIARIES**

**RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES** 

*(dollars in thousands, except per share data)*

**Adjusted Earnings Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net income | $76149 | $53911 | $149094 | $102339 |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction-related costs<sup>(a)</sup> |  |  |  | 327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment income | (613) |  | (733) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other nonoperating expenses<sup>(b)</sup> | 1019 | 521 | 1019 | 1013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible asset amortization | 2013 | 2013 | 4027 | 4027 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 8106 | 7764 | 16042 | 15403 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency transaction (gain) loss | (134) | 19 | 318 | 67 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cumulative tax effect of adjustments | (488) | (2590) | (2976) | (5232) |
| Adjusted earnings | $86052 | $61638 | $166791 | $117944 |
| Diluted earnings per share | $2.86 | $1.93 | $5.51 | $3.56 |
| Adjusted earnings per share | $3.23 | $2.21 | $6.16 | $4.11 |

---

**Adjusted EBITDA Measures**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net income | $76149 | $53911 | $149094 | $102339 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expenses | 10348 | 9709 | 20409 | 19972 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 82781 | 70954 | 163325 | 136551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency transaction (gain) loss | (134) | 19 | 318 | 67 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 24904 | 19651 | 42987 | 35878 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 8106 | 7764 | 16042 | 15403 |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction-related costs<sup>(a)</sup> |  |  |  | 327 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity method investment income | (613) |  | (733) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other nonoperating expenses<sup>(b)</sup> | 1019 | 521 | 1019 | 1013 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $202560 | $162529 | $392461 | $311550 |
| Adjusted EBITDA margin calculated as follows: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $764043 | $628436 | $1509584 | $1238325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | 202560 | 162529 | 392461 | 311550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA as a percentage of total revenue | 26.5% | 25.9% | 26.0% | 25.2% |

---

------

*(a) In the first quarter of 2024, the Company recorded $0.3 million ($0.2 million net of tax) of costs related to a consent solicitation for the Senior Notes due 2025.*

*(b) In the second quarter of 2025 and the first and second quarters of 2024, the Company recorded other nonoperating expense of $1.0 million ($0.8 million net of tax), $0.5 million ($0.4 million net of tax) and $0.5 million ($0.4 million net of tax), respectively, related to the early extinguishment of debt.*

------